Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China flag China · Delayed Price · Currency is CNY
3.490
+0.030 (0.87%)
Feb 3, 2026, 3:00 PM CST

SHA:600664 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
8,79010,4018,4457,5998,9407,997
Market Cap Growth
-20.86%23.17%11.14%-15.00%11.79%-15.83%
Enterprise Value
8,0459,8348,3738,60810,4448,672
Last Close Price
3.494.133.353.013.553.19
PE Ratio
19.4616.5421.3716.3424.09-
Forward PE
13.4214.9114.9114.9114.9114.91
PS Ratio
0.550.640.550.550.700.74
PB Ratio
1.371.711.561.542.022.01
P/TBV Ratio
1.682.122.001.982.692.68
P/FCF Ratio
50.9415.049.7814.27--
P/OCF Ratio
31.3813.138.8912.22--
EV/Sales Ratio
0.500.610.540.620.820.80
EV/EBITDA Ratio
9.839.239.5310.4814.57-
EV/EBIT Ratio
13.7011.5713.5415.4323.33-
EV/FCF Ratio
46.6314.229.7016.17--
Debt / Equity Ratio
0.190.290.340.440.520.45
Debt / EBITDA Ratio
1.521.582.012.483.06-
Debt / FCF Ratio
7.222.552.154.04--
Asset Turnover
1.131.131.121.051.040.89
Inventory Turnover
5.866.116.145.405.014.39
Quick Ratio
1.111.080.990.930.820.77
Current Ratio
1.451.361.261.201.111.07
Return on Equity (ROE)
7.84%12.00%9.15%10.94%9.75%-21.05%
Return on Assets (ROA)
2.59%3.70%2.81%2.65%2.27%-4.12%
Return on Invested Capital (ROIC)
9.26%15.90%10.15%8.31%5.82%-14.87%
Return on Capital Employed (ROCE)
8.60%13.10%10.50%10.30%9.00%-17.70%
Earnings Yield
5.11%6.05%4.68%6.12%4.15%-13.48%
FCF Yield
1.96%6.65%10.22%7.01%-2.67%-10.58%
Payout Ratio
5.04%7.49%11.17%11.68%16.59%-
Buyback Yield / Dilution
2.18%-1.82%4.40%-4.46%1.29%10.19%
Total Shareholder Return
2.18%-1.82%4.40%-4.46%1.29%10.19%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.